Bayesian Capital Management’s QuidelOrtho QDEL Stock Holding History

Bayesian Capital Management’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,400	Closed	-$775K	–	900
2024 Q4	$775K	Buy	+17,400	New	+$712K	0.09%	286
2024 Q3	–	Sell	-10,523	Closed	-$350K	–	974
2024 Q2	$350K	Buy	+10,523	New	+$430K	0.04%	468
2023 Q3	–	Sell	-2,700	Closed	-$224K	–	932
2023 Q2	$224K	Buy	+2,700	New	+$236K	0.02%	615
2021 Q1	–	Sell	-5,400	Closed	-$970K	–	663
2020 Q4	$970K	Buy	5,400 +870	+19%	+$193K	0.25%	109
2020 Q3	$994K	Buy	+4,530	New	+$1.01M	0.24%	107
2018 Q4	–	Sell	-3,100	Closed	-$202K	–	756
2018 Q3	$202K	Sell	3,100 -1,180	-28%	-$82.5K	0.03%	565
2018 Q2	$285K	Buy	+4,280	New	+$259K	0.06%	420

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bayesian Capital Management's QDEL Position: Q1 2025 in Review

Bayesian Capital Management sold out of QuidelOrtho (QDEL) in Q1 2025, closing a stake of 17,400 shares — an estimated $775K sold.

Bayesian Capital Management first reported a position in QDEL in Q2 2018 and held it in 7 quarters. The position peaked at $994K in Q3 2020. 266 funds tracked by Wall St. Rank hold QDEL as of Q1 2025.

Bayesian Capital Management reported no remaining QuidelOrtho position as of Q1 2025 after selling out during the quarter.
Bayesian Capital Management sold 17,400 QuidelOrtho shares in Q1 2025, an estimated $775K.
Bayesian Capital Management first reported a position in QuidelOrtho in Q2 2018 and held it in 7 quarters.
Bayesian Capital Management's QuidelOrtho position peaked at $994K in Q3 2020.
266 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.